BATS:NOBL

ProShares S&P 500 Aristocrats ETF Stock Forecast, Price & News

$90.43
+1.77 (+2.00 %)
(As of 06/21/2021 04:00 PM ET)
Add
Today's Range
$89.31
$90.46
50-Day Range
$87.48
$93.41
52-Week Range
$55.69
$67.97
Volume322,211 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NOBL News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares S&P 500 Aristocrats ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares S&P 500 Aristocrats ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:NOBL
Inception Date10/9/2013
Fund ManagerMichael Neches, Devin Sullivan
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkS&P 500 Dividend Aristocrats Index
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$8.51 billion
Average Daily Volume$390,851.80
Discount/Premium0.01%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerRBC Capital Markets

Geographic Exposure of NOBL

Currency Exposure of NOBL

Sector Exposure of NOBL

Industry Exposure of NOBL

speech bubbles
speech bubbles











ProShares S&P 500 Aristocrats ETF (BATS:NOBL) Frequently Asked Questions

What stocks does MarketBeat like better than ProShares S&P 500 Aristocrats ETF?

Wall Street analysts have given ProShares S&P 500 Aristocrats ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ProShares S&P 500 Aristocrats ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ProShares S&P 500 Aristocrats ETF's stock been impacted by Coronavirus (COVID-19)?

ProShares S&P 500 Aristocrats ETF's stock was trading at $63.55 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NOBL stock has increased by 42.3% and is now trading at $90.43.
View which stocks have been most impacted by COVID-19
.

What other stocks do shareholders of ProShares S&P 500 Aristocrats ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares S&P 500 Aristocrats ETF investors own include AT&T (T), Johnson & Johnson (JNJ), Intel (INTC), Chevron (CVX), 3M (MMM), Exxon Mobil (XOM), AbbVie (ABBV), The Walt Disney (DIS), The Home Depot (HD) and The Coca-Cola (KO).

What is ProShares S&P 500 Aristocrats ETF's stock symbol?

ProShares S&P 500 Aristocrats ETF trades on the BATS under the ticker symbol "NOBL."

Who are ProShares S&P 500 Aristocrats ETF's major shareholders?

ProShares S&P 500 Aristocrats ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Morgan Stanley (0.00%), UBS Group AG (0.00%), Royal Bank of Canada (0.00%), IAM Advisory LLC (0.00%), Ameriprise Financial Inc. (0.00%) and Commonwealth Equity Services LLC (0.00%).

Which major investors are selling ProShares S&P 500 Aristocrats ETF stock?

NOBL stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Financial Management Concepts Corp ADV, JBF Capital Inc., Summit Financial Wealth Advisors LLC, Paragon Capital Management Ltd, Kestra Advisory Services LLC, Migdal Insurance & Financial Holdings Ltd., and Quest Investment Management LLC.

Which major investors are buying ProShares S&P 500 Aristocrats ETF stock?

NOBL stock was acquired by a variety of institutional investors in the last quarter, including Morgan Stanley, JPMorgan Chase & Co., Ameriprise Financial Inc., Rockefeller Capital Management L.P., Cresset Asset Management LLC, CIBC World Markets Inc., Cambridge Investment Research Advisors Inc., and Royal Bank of Canada.

How do I buy shares of ProShares S&P 500 Aristocrats ETF?

Shares of NOBL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares S&P 500 Aristocrats ETF's stock price today?

One share of NOBL stock can currently be purchased for approximately $90.43.


This page was last updated on 6/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.